Shukra Pharmaceuticals Share Price
₹215.90 +4.2 (1.98%)
22 Jan, 2025 14:28
Start SIP in SHUKRAPHAR
Start SIPPerformance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month + 112.12%
- Over 3 Month + 206.63%
- Over 6 Month + 156.26%
- Over 1 Year + 573.63%
Smart Investing Starts Here Start SIP with Shukra Pharmaceuticals for Steady Growth!
Shukra Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Shukra Pharmaceuticals Financials
Shukra Pharmaceuticals Technicals
EMA & SMA
Current Price
₹215.90
+
4.2
(1.98%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹169.49
- 50 Day
- ₹128.75
- 100 Day
- ₹105.23
- 200 Day
- ₹88.62
Resistance and Support
211.7
- R3 211.70
- R2 211.70
- R1 211.70
- S1 211.70
- S2 211.70
- S3 211.70
Shukra Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-01-09 | Others | Inter alia, approving the offer and issue of equity shares of the Company by way of a rights issue to eligible shareholders of the Company. alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company. |
2024-11-14 | Quarterly Results | |
2024-09-28 | Rights issue of Equity Shares | |
2024-08-12 | Quarterly Results | |
2024-05-29 | Audited Results & Dividend |
Shukra Pharmaceuticals F&O
About Shukra Pharmaceuticals
- NSE Symbol
- SHUKRAPHAR
- BSE Symbol
- 524632
- ISIN
- INE551C01028
Similar Stocks to Shukra Pharmaceuticals
Shukra Pharmaceuticals FAQs
Shukra Pharmaceuticals share price is ₹215 As on 22 January, 2025 | 14:14
The Market Cap of Shukra Pharmaceuticals is ₹945.4 Cr As on 22 January, 2025 | 14:14
The P/E ratio of Shukra Pharmaceuticals is 65.5 As on 22 January, 2025 | 14:14
The PB ratio of Shukra Pharmaceuticals is 17.4 As on 22 January, 2025 | 14:14
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.